Central nervous system depression after ingestion of RenewTrient

N Engl J Med. 1999 Feb 18;340(7):570. doi: 10.1056/NEJM199902183400718.
No abstract available

Publication types

  • Letter

MeSH terms

  • 4-Butyrolactone / adverse effects*
  • Antidotes / therapeutic use*
  • Central Nervous System / drug effects
  • Cholinesterase Inhibitors / therapeutic use*
  • Depression, Chemical
  • Humans
  • Physostigmine / therapeutic use*

Substances

  • Antidotes
  • Cholinesterase Inhibitors
  • Physostigmine
  • 4-Butyrolactone